Lamivudin-Mepha 150

Lamivudin-Mepha 150 is a medicine authorised by Swissmedic under authorisation number 60516. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 05 August 2010 and the authorisation is valid without a time limit. ATC code J05AF05 places the medicine in the group Antivirals for systemic use.

  • Dispensing category A
  • Authorisation number 60516
  • ATC J05AF05
  • Synthetic medicines
Authorisation data
Authorisation number60516
NameLamivudin-Mepha 150
Full nameLamivudin-Mepha 150, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ05AF05
First authorisation05 August 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Lamivudin-Mepha 150, FilmtablettenA05 August 2010
2Lamivudin-Mepha 300, FilmtablettenA05 August 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
360Tablette(n)J05AF0508.03.0.A
430Tablette(n)J05AF0508.03.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Lamivudin-Mepha 150 authorised in Switzerland?

Yes. Lamivudin-Mepha 150 is authorised by Swissmedic under authorisation number 60516, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Lamivudin-Mepha 150 have?

Lamivudin-Mepha 150 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Lamivudin-Mepha 150?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com